IN vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine

Biochemical Pharmacology

Volumn 43, Issue 11, 1992, Pages 2427-2433

  Galli, Alessandro ^a   Mori, Francesca ^a   Gori, Ilaria ^a   Lucherini, Marzia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DEXTRORPHAN; DYFLOS; EDROPHONIUM; NEOSTIGMINE; PHYSOSTIGMINE; RANITIDINE; TACRINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HORSE; INVERTEBRATE; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ACETYLCHOLINESTERASE; BINDING SITES; BUTYRYLCHOLINESTERASE; CHOLINESTERASE REACTIVATORS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOFLUROPHATE; NEOSTIGMINE; ORGANOPHOSPHORUS COMPOUNDS; PHYSOSTIGMINE; SUPPORT, NON-U.S. GOV'T; TACRINE;

EID: 0026742286     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(92)90323-B     Document Type: Article

References (30)

1. Enzyme inhibiting action of tetra-hydroaminoacridine and its structural fragments
2. A hydrophobic binding site in acetylcholinesterase
3. Kinetics of inhibition of cholinesterase by 1234-tetrahydro-9-aminoacridine in vitro
4. The cholinergic pharmacology of tetrahydro-aminoacridine in vivo and in vitro
5. Tacrine in the treatment of Alzheimer's disease—a clinical update and recent pharmacologic studies
6. Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo
7. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication
8. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
9. Physostigmine—an overview as pretreatment drug for organophosphate intoxication
10. A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds
11. Protective effect of 1234-tetrahydro-9-aminoacridine on acetylcholinesterase inhibition by organophosphorus inhibitors
12. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate—a circular dichroism study
13. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine
14. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons
15. Tetra-hydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity
16. Tetra-hydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes
17. Tacrine slows the rate of ageing of sarininhibited acetylcholinesterase
18. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation
19. A new and rapid colorimetric determination of acetylcholinesterase activity
20. Mode of action of anticholinesterases
21. Blood cholinesterase inhibition as a guide to the efficacy of putative therapies for Alzheimer's dementia: comparison of tacrine and physostigmine
22. Inhibition of acetyl-cholinesterase by various opioids
23. Effect of ranitidine on ileal myenteric plexus preparation and on acetyl-and butylrylcholinesterase
24. In vitro and in vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates
25. Protection against diisopropylfluorophosphate intoxication by meptazinol
26. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine)
27. Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates
28. Assessment of the competition between tacrine and gallamine for binding sites on acetylcholinesterase
29. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes